UMIN-CTR Clinical Trial

Recruitment status Terminated
Unique ID issued by UMIN UMIN000020409
Receipt No. R000023557
Official scientific title of the study Effect of nutritional vitamin D supplements in hemodialysis patients
Date of disclosure of the study information 2015/12/31
Last modified on 2017/03/10 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Effect of nutritional vitamin D supplements in hemodialysis patients

Title of the study (Brief title) Nutritional vitamin D supplementation in hemodialysis patients
Region
Japan

Condition
Condition CKD-5D
Classification by specialty
Medicine in general Nephrology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To investigate the serum 25(OH)D level in hemodialysis patients. Additionally, to assess the effects of supplementation in hemodialysis patients with nutritional vitamin D.

Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2 Pragmatic
Developmental phase Not applicable

Assessment
Primary outcomes Serum 25(OH)D and 1,25(OH)2D levels at 6 and 12 months after the beginning of supplementation of nutritional vitamin D.
Key secondary outcomes Serum calcium, phosphorus, albumin, and intact parathyroid hormone levels, CRP(C-reactive protein) levels, Serum fibroblast growth factor 23 (FGF 23)levels, hemoglobin (Hb) levels,
changes in blood pressure, medication use (erythrocyte-stimulating agents, activated vitamin D)

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control No treatment
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 3
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 Ingestion of ergocalciferol (vitamin D2, which comes from plant sources), 400 IU daily for 6 months of the first half, and continue to take it at the same dose for 6 months of the latter half.
Interventions/Control_2 Ingestion of ergocalciferol (vitamin D2, which comes from plant sources), 400 IU daily for 6 months of the first half, and continue to take it at the same dose, additionally oral cholecalciferol (vitamin D3, which comes from animal sources), 7000 IU weekly for 6 months of the latter half.
Interventions/Control_3 Control group
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria 1. hemodialysis patients
2. Subjects who agree to participate in the current study with a written informed consent
Key exclusion criteria 1. Subjects who are at risk of having allergic reactions to drugs or supplements
2. Subjects who regularly take
nutritional vitamin D
Target sample size 40

Research contact person
Name of lead principal investigator Masanori Okamoto
Organization Saiseikai Wakayama Hospital
Division name Kidney Center
Address 12 banchou 45, Wakaya, Japan
TEL 073-424-5185
Email mokamoto@wakayama-med.ac.jp

Public contact
Name of contact person Masanori Okamoto
Organization Saiseikai Wakayama Hospital
Division name Kidney Center
Address 12 banchou, Wakayama, Japan
TEL 073-424-5185
Homepage URL
Email mokamoto@wakayama-med.ac.jp

Sponsor
Institute Saiseikai Wakayama Hospital
Institute
Department

Funding Source
Organization Social Welfare Organization Saiseikai Imperial Gift Foundation, Inc
Organization
Division
Category of Funding Organization Non profit foundation
Nationality of Funding Organization Japan

Other related organizations
Co-sponsor
Name of secondary funder(s) Division of Nephrology, Wakayama Medical University, Japan

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2015 Year 12 Month 31 Day

Progress
Recruitment status Terminated
Date of protocol fixation
2015 Year 08 Month 01 Day
Anticipated trial start date
2015 Year 08 Month 10 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2015 Year 12 Month 31 Day
Last modified on
2017 Year 03 Month 10 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000023557